Latest filing published 11 Feb 2014 for Revance Therapeutics, Inc..
Insider track record
No signal scores available.
NovaQuest Pharma Opportunities Fund III, L.P.: trading record in brief
NovaQuest Pharma Opportunities Fund III, L.P. discloses dealings in Revance Therapeutics, Inc. to SEC (Form 4). In total, 3 filings cover trades dated 11 February 2014.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 11 February 2014 came the latest disclosure, a transaction in Revance Therapeutics, Inc. Most trades are made public on the day they happen. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to NovaQuest Pharma Opportunities Fund III, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,039,382 sharesCommon StockSEC:0001209191-14-009001:0
- 658,551 sharesCommon StockSEC:0001209191-14-009001:1
- 398,717 sharesCommon StockSEC:0001209191-14-009001:2
3 of 3 declarations
